Meeting current physical activity guidelines — just 150 minutes of moderate-intensity exercise per week, or 75 minutes of vigorous activity — reduces the risk of developing 14 different types of cancer by a median of 31%, according to the largest analysis ever conducted on physical activity and cancer risk.
The Study
The meta-analysis, published in British Journal of Sports Medicine, pooled individual-participant data from 126 prospective cohort studies involving 1,440,000 participants from North America, Europe, Asia, and Australia. The analysis examined associations between leisure-time physical activity and 26 cancer types, with a minimum 10-year follow-up per participant.
Cancer Types Most Protected
The strongest inverse associations between physical activity and cancer risk were observed for:
- Colon cancer: 43% risk reduction
- Breast cancer: 38% risk reduction
- Endometrial cancer: 36% risk reduction
- Kidney cancer: 29% risk reduction
- Bladder cancer: 27% risk reduction
- Esophageal cancer: 26% risk reduction
- Gastric cancer: 22% risk reduction
No significant association was found for pancreatic cancer, thyroid cancer, or melanoma. Prostate cancer showed a modest non-significant reduction.
Dose-Response Relationship
Critically, the analysis revealed a clear dose-response relationship: more activity conferred greater protection, with no evidence of a ceiling effect up to approximately 600 minutes per week of moderate activity. Even relatively small amounts of exercise — as little as 60 minutes per week — were associated with measurable risk reduction compared to complete inactivity.
“If exercise were a pill, it would be the most widely prescribed drug in history. The evidence for cancer prevention is now unequivocal and the dose is achievable for most people.”
— Dr. Christine Friedenreich, Alberta Health Services Cancer Research, lead author
Biological Mechanisms
Physical activity influences cancer risk through multiple biological pathways:
- Inflammation: Exercise reduces systemic inflammation — a key cancer promoter
- Insulin and IGF-1: Regular activity improves insulin sensitivity and lowers circulating insulin-like growth factor 1
- Sex hormones: Reduces circulating estrogen — particularly relevant for breast and endometrial cancer
- Immune surveillance: Exercise enhances NK cell and cytotoxic T cell activity, improving the body’s ability to detect and destroy nascent cancer cells
- Gut transit time: Reduces exposure of colonic mucosa to carcinogens in stool
Translating Evidence to Policy
Despite this evidence, the WHO estimates that 28% of adults globally — and 42% of American adults — do not meet minimum physical activity guidelines. The authors urge oncologists, primary care physicians, and public health authorities to make physical activity promotion a central pillar of cancer prevention strategy, on par with smoking cessation and dietary guidance.
Exercise oncology — integrating structured exercise programs into cancer treatment and survivorship — is gaining recognition as a distinct clinical subspecialty. Growing evidence also suggests regular exercise improves outcomes in patients undergoing cancer treatment, reducing fatigue, chemotherapy toxicity, and recurrence risk.
Leave a Reply